CoreTissue BioEngineering

Private

YokohamaHealthcare & Life Scienceshttps://coretissue.com/

Last Round

Grant

Jan 9, 2026

Total Funding Raised

$11.36M

Company Overview

CoreTissue BioEngineering is a bioengineering company that develops, manufactures, and sells medical devices using proprietary decellularization technology for anterior cruciate ligament reconstruction.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

ACL reconstructionregenerative ligamentdecellularization technologytissue engineeringbiocompatible scaffoldregenerative medicineACL graftxenograftautograft alternativeorthopedic medical devicesoft tissue repairsports medicineclinical trialsAnterior Cruciate Ligament reconstruction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CoreTissue BioEngineering Comps

Public and private peers based on sector, stage, and business model.

CoreTissue BioEngineering comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CoreTissue BioEngineering Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jan 9, 2026
Series A Extension	Nov 10, 2025
Accelerator	Jul 29, 2024
Series A	Jan 1, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Yoji Jokura

President and CEO

Executive Team

CoreTissue BioEngineering Investors

Notable investors and investment history

CoreTissue BioEngineering investors
Investor	Rounds
New Energy and Industrial Technology Development Organization	Grant
WERU Investment Co.	Series A Extension
Japan Science and Technology Agency	Series A
Mitsui Sumitomo Insurance Capital Co., Ltd.	Series A Extension
Fogarty Innovation	Accelerator

View all Investors

CoreTissue BioEngineering Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

CoreTissue BioEngineering Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CoreTissue BioEngineering's valuation, stock price, and market status.

Firmographic Details

HeadquartersYokohama

Employee Range4

Year Founded2016

Last FundingJan 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.